Risk Stratification of Opioid Misuse among Patients with Cancer Pain Using the SOAPP-SF

Koyyalagunta, Dhanalakshmi; Bruera, Éduardo; Aigner, Carrie J.; Harun, Nusrat; Driver, Larry C.; Novy, Diane M.

doi:10.1111/pme.12100

Cited by 102 publications

(94 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…shown that anxiety and depression can have negative effects on pain and an increased risk of misusing opioids [6,33,34]. However, as mentioned, there is a lack of research regarding the mediating effects of depression and anxiety in the relationship between pain and prescription opioid misuse.…”

Section: Discussionmentioning

confidence: 95%

Evaluation of How Depression and Anxiety Mediate the Relationship between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population

Arteta

Cobos

et al. 2015

Pain Med

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

Evaluation of How Depression and Anxiety Mediate the Relationship between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population

Arteta

Cobos

et al. 2015

Pain Med

View full text Add to dashboard Cite

show abstract

“…8 Furthermore, there is sparse literature regarding the use and implementation of screening tools in the treatment of cancer pain. 9,10 One study reported the implementation of the SOAPP-short form (SOAPP-SF). 10 The SOAPP-SF is an abbreviated 5-item self-report that was created, in part, to reduce the time burden of patients in completing the 14-item SOAPP questionnaire.…”

Section: Introductionmentioning

confidence: 99%

A Single-Center, Retrospective Analysis Evaluating the Utilization of the Opioid Risk Tool in Opioid-Treated Cancer Patients

Joseph¹,

Horton²,

Hwang³

et al. 2014

Journal of Pain & Palliative Care Pharmacotherapy

View full text Add to dashboard Cite

The Opioid Risk Tool (ORT) is a screening tool used to assess risk of opioid misuse by stratifying aberrant drug-seeking behaviors and/or identifying known risk factors for drug abuse. The objectives of this study were to risk stratify opioid misuse in a cancer pain population and determine the most common patient risk factors associated with misuse utilizing the ORT. This was a retrospective analysis conducted at an academic comprehensive cancer center. Patients were referred by an oncologist or hematologist to an outpatient palliative care clinic. One-hundred and fourteen patients with cancer (n = 107) or sickle cell disease (n = 7) were evaluated from July 2012 to July 2013. During the clinical interview, patients responded to a clinician administered ORT. Based on the ORT score, patients were stratified into low, moderate, or high risk for opioid misuse. Sample size included 57 men and 57 women. Sixty-five, 21, and 28 patients were deemed low, moderate, and high risk based on the ORT, respectively. The most common risk factors for opioid misuse were a history of depression (women = 32; men = 22) and family history of alcohol abuse (women = 26; men = 22). There was no difference between men and women in the prevalence of depression (P = .17) or family history of alcohol abuse (P = .57). The least common risk factor was a personal history of prescription drug abuse (n = 1) in women and history of preadolescent sexual abuse in men (n = 0). Twenty-five percent (n = 28) of the sample population were deemed high risk based on the ORT. Screening of cancer patients in the palliative care setting suggests that risk factors for opioid misuse exist. Stratifying patients based on a routine screening tool may help identify cancer patients at risk for aberrant drug behaviors.

show abstract

“…The SOAPP-R may be the most effective at predicting aberrance according to recent studies, but all screening tests are more helpful when interpreted in clinical context [58]. The SOAPP-SF (short-form version) has also been shown to be an effective screening tool, and, with only five items, is easy to incorporate into the clinical interview [59]. Consistency in using the same screener in the same manner for all patients and then appropriately interpreting the result is important, so each provider or clinical setting should determine the instruments most suited to their situation and become adept in their use.…”

Section: Addiction Risk Assessmentmentioning

confidence: 97%

Opioid risk assessment in palliative medicine

Krashin

Murinova

Jumelle

et al. 2015

Expert Opinion on Drug Safety

View full text Add to dashboard Cite

Palliation of severe pain at the end of life is probably the most widely accepted indication for chronic opioid therapy. At increased doses, adverse effects of opioids may limit or interfere with the benefits of treatment. Careful screening and follow-up will allow risk factors to be recognized and addressed when possible. The use of adjunctive treatments for pain may reduce opioid requirements and yield better outcomes.

show abstract

Risk Stratification of Opioid Misuse among Patients with Cancer Pain Using the SOAPP-SF

Cited by 102 publications

References 29 publications

Evaluation of How Depression and Anxiety Mediate the Relationship between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population

Evaluation of How Depression and Anxiety Mediate the Relationship between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population

A Single-Center, Retrospective Analysis Evaluating the Utilization of the Opioid Risk Tool in Opioid-Treated Cancer Patients

Opioid risk assessment in palliative medicine

Contact Info

Product

Resources

About